Skip to main content

LTGO · Latigo Biotherapeutics, Inc. · Shareholders & Ownership

Track LTGO — free
$15.26 +0.24 (+1.60%) At close · Oct 26
Market Cap
$954.38M
Shares
66.30M
Volume · Oct 26 165.33K Avg daily vol (56 sessions) 349.92K

Every disclosed holder of LTGO in one list: 13F institutions, Schedule 13D and 13G filers, insiders (Forms 3, 4 and 5) and registered funds, each from its own latest filing. Holders nest by CIK and SEC reporting links, never by name, and each is summed once.

Who Owns LTGO

Holder group Shares % Out
Institutional (13F) 0 0.00%
Insiders (Forms 3, 4, 5) 52,875,197 79.75%
13D/G-only blocks 12,927,523 19.50%
Remaining 496,627 0.75%
Registered funds (N-PORT, not summed) 0 0.00%

Shares outstanding: 66,299,347, the issuer's latest cover-page count restated onto today's split basis.

13D/G-only counts each filer's latest 13D or 13G that no 13F report of the listing contains, that names no 13F filer and that no counted insider files. Funds are never summed: their shares sit inside their advisers' 13F reports.

Holders of LTGO

# Holder Shares
1
SEIDENBERG BETH C
Insider CIK 1184592 · Aug 10, 2026
Director, issuer-wide
13,199,669
2
Westlake BioPartners Fund I, L.P.
Insider CIK 1749591 · Aug 10, 2026
10% Owner, issuer-wide
13,199,669
3
Foresite Capital Management V, LLC
Insider CIK 1792206 · Aug 10, 2026
10% Owner, issuer-wide
9,181,328
4
Tananbaum James B.
Insider CIK 1581754 · Aug 10, 2026
Director, issuer-wide
9,181,328
5
5AM Ventures VI, L.P.
Insider CIK 1753037 · Aug 10, 2026
10% Owner, issuer-wide
7,325,962
6
RA CAPITAL MANAGEMENT, L.P.
13G CIK 1346824 · Registered investment adviser · Aug 10, 2026
Rule 13d-1(c), passive investor
5,295,690
7
Deep Track Capital, LP
13G CIK 1856083 · Investment adviser · Aug 7, 2026
Rule 13d-1(c), passive investor
4,446,656
8
AI Biotechnology LLC
13G CIK 1942670 · Unknown · Aug 11, 2026
Rule 13d-1(c), passive investor
3,185,177
9
Foresite Capital Fund VI, L.P.
13D CIK 1932516 · Unknown · Aug 10, 2026
Item 4 purpose: Passive investment
not summed
2,203,800
10
Sanofi
Insider CIK 1121404 · Aug 10, 2026
10% Owner, issuer-wide
672,788
11
Farzan Nima
Insider CIK 1808296 · Aug 6, 2026
Director, issuer-wide
114,453

Shares are restated onto today's split basis. Change compares each row with the same holder's previous filing in the same source; a dash means there is none to compare. Nested 13D/G, insider and fund rows are not summed, since a 13F report already holds them.

Key facts CIK 2056611 CUSIP 517954103 Visit website Investor relations